Visiometrics S.L was acquired by Halma Plc in 2015. The full value of the deal, including earn-outs until 2020 is €125 million, giving Atlas Capital Group’s investors up to 8X on their investment.
Visiometrics S.L. has developed the HD Analyzer, a revolutionary product for complete and objective eye examinations. Today, ophthalmologists and optometrists use subjective and incomplete refraction tools to diagnose vision problems and explain symptoms to their patients. The HD Analyzer is a super-refractor, allowing the physician to see exactly what the patient sees. The deliverable is user friendly outputs that helps doctors share and explain the optical phenomena with the patient.
The HD Analyzer has been developed over the past 13 years by some of the most prominent names in the industry, under the lead of the CEO, Mr Jan Bonel. The HD Analyzer is now ready for the general market. As many eye diseases are a direct result of old age, the US ophthalmic medical device market is growing substantially. Visiometrics has secured support from over 20 Key Opinion Leaders worldwide to drive the adaptation and reputation of this new technology. Thanks to this support, the marketing and sales are already highly successful.
Atlas Capital Group will offer a total of 40% of VPD to its investors, with roughly half released to clients so far.